Dr. Mark Smolenski, M.D

NPI: 1467571257
Total Payments
$5,178
2024 Payments
$1,760
Companies
17
Transactions
108
Medicare Patients
39
Medicare Billing
$34,172

Payment Breakdown by Category

Food & Beverage$4,040 (78.0%)
Travel$1,038 (20.0%)
Education$100.19 (1.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,040 102 78.0%
Travel and Lodging $1,038 1 20.0%
Education $100.19 5 1.9%

Top Paying Companies

Company Total Records Latest Year
Neuronetics, Inc. $1,550 2 $0 (2024)
Otsuka America Pharmaceutical, Inc. $863.37 19 $0 (2019)
Allergan, Inc. $555.41 9 $0 (2020)
ABBVIE INC. $554.38 23 $0 (2024)
Lundbeck LLC $347.01 15 $0 (2022)
Sunovion Pharmaceuticals Inc. $283.48 15 $0 (2022)
ITI, Inc. $190.72 6 $0 (2023)
Harmony Biosciences LLC $156.43 2 $0 (2023)
Neurocrine Biosciences, Inc. $125.00 1 $0 (2019)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $121.84 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,760 6 Neuronetics, Inc. ($1,550)
2023 $743.25 18 AbbVie Inc. ($262.98)
2022 $483.40 29 ABBVIE INC. ($202.78)
2021 $67.70 4 Lundbeck LLC ($24.95)
2020 $172.69 3 Allergan, Inc. ($125.00)
2019 $1,169 29 Otsuka America Pharmaceutical, Inc. ($445.75)
2018 $498.84 14 Allergan Inc. ($298.70)
2017 $282.59 5 Otsuka America Pharmaceutical, Inc. ($249.14)

All Payment Transactions

108 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
11/01/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $28.31 General
Category: NEUROSCIENCE
08/07/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $121.84 General
Category: PSYCHIATRY
06/27/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.31 General
Category: NEUROSCIENCE
03/01/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.00 General
Category: NEUROSCIENCE
02/23/2024 Neuronetics, Inc. NEUROSTAR TMS THERAPY SYSTEM (Device) Travel and Lodging Cash or cash equivalent $1,038.01 General
Category: NEUROSTAR TMS THERAPY SYSTEM
02/23/2024 Neuronetics, Inc. NEUROSTAR TMS THERAPY SYSTEM (Device) Food and Beverage Cash or cash equivalent $511.79 General
Category: NEUROSTAR TMS THERAPY SYSTEM
12/09/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $29.61 General
Category: NEUROSCIENCE
11/23/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.33 General
Category: NEUROSCIENCE
09/14/2023 Harmony Biosciences LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $31.44 General
Category: SLEEP MEDICINE
08/23/2023 ITI, Inc. CAPLYTA (Drug) Education In-kind items and services $48.84 General
Category: PSYCHIATRY
08/23/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $29.37 General
Category: PSYCHIATRY
08/16/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $1.99 General
Category: NEUROSCIENCE
07/27/2023 Harmony Biosciences LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $124.99 General
Category: SLEEP MEDICINE
07/25/2023 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $115.14 General
Category: CNS
07/19/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.45 General
Category: NEUROSCIENCE
07/13/2023 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $34.54 General
Category: Psychology/Psychiatric
07/07/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.61 General
Category: NEUROSCIENCE
06/08/2023 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $16.39 General
Category: Neurology
04/28/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $31.79 General
Category: NEUROSCIENCE
04/26/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $123.51 General
Category: NEUROSCIENCE
03/17/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $28.67 General
Category: PSYCHIATRY
02/07/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $20.70 General
Category: Central Nervous System
02/02/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.69 General
Category: NEUROSCIENCE
01/17/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $30.19 General
Category: PSYCHIATRY
12/19/2022 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $34.54 General
Category: Psychology/Psychiatric

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 1 14 147 $29,400 $12,353
2021 1 14 151 $30,200 $12,917
2020 1 11 130 $26,000 $8,902
Total Patients
39
Total Services
428
Medicare Billing
$34,172
Procedure Codes
3

All Medicare Procedures & Services

3 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 14 147 $29,400 $12,353 42.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 14 151 $30,200 $12,917 42.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 11 130 $26,000 $8,902 34.2%

About Dr. Mark Smolenski, M.D

Dr. Mark Smolenski, M.D is a Psychiatry healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467571257.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Smolenski, M.D has received a total of $5,178 in payments from pharmaceutical and medical device companies, with $1,760 received in 2024. These payments were reported across 108 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,040).

As a Medicare-enrolled provider, Smolenski has provided services to 39 Medicare beneficiaries, totaling 428 services with total Medicare billing of $34,172. Data is available for 3 years (2020–2022), covering 3 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Psychiatry
  • Location Mountain View, CA
  • Active Since 03/29/2007
  • Last Updated 01/07/2010
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1467571257

Products in Payments

  • NEUROSTAR TMS THERAPY SYSTEM (Device) $1,550
  • REXULTI (Drug) $1,161
  • VRAYLAR (Drug) $1,110
  • CAPLYTA (Drug) $312.56
  • LATUDA (Drug) $283.48
  • WAKIX (Drug) $156.43
  • INGREZZA (Drug) $125.00
  • LYBALVI (Drug) $115.14
  • Auvelity (Drug) $102.94
  • Trintellix (Drug) $83.53
  • SPRAVATO (Drug) $58.78
  • BRINTELLIX (Drug) $49.14
  • AUSTEDO (Drug) $20.70
  • TRINTELLIX (Drug) $19.55
  • UZEDY (Drug) $16.39
  • Evekeo (Drug) $13.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Mountain View